GC Biopharma
KSC:006280 · KR7006280002
BiotechnologySmall
360
52
Value62
Quality67
Growth50
Safety25
Sentiment47
Value Creation8/20creating some value
- Creates more value than its capital costs
- Owner earnings growing
- Owner earnings per share growing
- Reinvests at strong returns
- Solid earnings base
What this means
GC Biopharma clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.
Profile
CountrySouth Korea
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeKOSE
Employees313
Websitegcbiopharma.com
ISINKR7006280002
Last UpdateApr 2, 2026
Indices
Themes
HematologyPain ManagementImmunologyInfectious DiseasesInflammationBiotechnologyHealth CarePharmaceutical
Description
Analysis
Quality compounder
GC Biopharma Corp. is a quality compounder: a well-run business trading at a price that reflects what it is worth.
360° rank · history
1007550250
68
2026
All-time high
75
Mar 2026
All-time low
68
Jun 2026
Average rank
72
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.
Similar Stocks
The companies this stock is ranked against.
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100